- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02023138
Evaluation of the Acceptability, Feasibility and Effectiveness of Two Methods of Involvement of Patients With Cognitive Disability in Clinical Guidelines Development: a Randomized Crossover Pilot Trial
December 23, 2013 updated by: Marie-Eve Lamontagne, Laval University
There is a lack of evidence about the best method to involve the patient and population (IPP) into clinical practice guidelines (CPG) development.
The goal of this pilot study is to document the acceptability, feasibility and effectiveness of two methods for the implication of patients with a traumatic brain injury (TBI) in CPG development.
Method: A single blind, randomized crossover trial will be performed with patients having a TBI.
Participants: A convenience sample of 20 patients a) with a moderate-to-severe TBI (Glascow Coma Scale <13), b) living with a TBI for two to four years, c) French-speaking, d) able to use a computer and e) able to participate in a two-hour group meeting will be recruited among the members of the Associations TCC Des Deux Rives.
Procedures: The patients will first receive a in-person training on guidelines and IPP.
They will be randomized into Group 1 or Group 2 by a researcher blinded to experimentation.
They will experiment either group discussion (control intervention) or a Wiki (experimental intervention).
Phase 1: A week after the training, Group 1 participants will be invited to a discussion group animated by an experimented moderator, where they will be asked to discuss a CPG recommendation chosen by the research team in an existing CPG.
The participants will be asked : 1) about their opinion of the recommendation; 2) if they have a preference in regard to the recommendation ; 3) if they have some modification, correction or addition to bring to this recommendation.
In the mean time, Group 2 participants will receive an email presenting a link to a Wiki.
They will be invited to answer the same three questions as Group 1, but using a Wiki platform.
The patients will have a week to interact and answer the questions; recalls could be sent by email if required.
At the end of Phase 1, participants of both groups will fill a questionnaire documenting the acceptability of the method experimented.
Phase 2: As per the crossover design, the Group 1 participants will then be assigned to the Wiki intervention and the Group 2 participants will be assigned to the discussion group intervention.
The procedure will be repeated with a second recommendation.
At the end of Phase 2, the patients will be asked to answer a short survey to validate their preferences about the two methods.
Tools: The acceptability of the methods will be evaluated with a questionnaire adapted from Sidani and al. and validated with three TBI individuals.
The feasibility of the intervention will be evaluated using a) the number of participants who reached the group or the Wiki, b) the number of participants who completed the intervention c) the number of support interventions required in the group and in the Wiki.
The effectiveness of the two methods will be evaluated by submitting the adapted recommendations to a panel of expert clinicians evaluators blinded to the methodologies of recommendations adaptation.
They will be invited to rate the clarity, accuracy, appropriateness and usefulness of the recommendations.
Analysis: Feasibility indicators will be reported using descriptive statistics.
Within-subject analysis using non-parametric statistics will be performed to assess the acceptability of the two methods.
AC1 coefficient of raters' agreement will be calculated on the expert evaluation scores, and the effectiveness of the methods will be compared using appropriate non parametric statistics to.
Impact: This pilot trial will be the first one to evaluate methodologies for involving disabled individuals into CPG development.
Study Overview
Study Type
Interventional
Enrollment (Anticipated)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Quebec
-
Québec, Quebec, Canada
- Association de personnes TCC du Québec
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- having suffered a moderate-to-severe TBI (Glascow Coma Scale <13)
- living with a TBI for two to four years
- French-speaking
- able to use a computer
- able to participate in a two-hour group meeting
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Focus group
|
Two hours focus group to allow the participants to modify a clinical practice guideline recommendation
A specially tailored interactive communication website (Wiki) to allow the participants to modify a clinical practice guideline recommendation
|
|
Experimental: Wiki
|
Two hours focus group to allow the participants to modify a clinical practice guideline recommendation
A specially tailored interactive communication website (Wiki) to allow the participants to modify a clinical practice guideline recommendation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability
Time Frame: Immediatly (less than 12 hours) after the intervention, at the end of week 2 and week 3.
|
The acceptability of the method will be evaluated through individual questionnaire administred seven days after having make the wiki available, or immediatly after the focus group.
|
Immediatly (less than 12 hours) after the intervention, at the end of week 2 and week 3.
|
|
Feasibility
Time Frame: At the end of the experimentation of the two methods (end of week 3)
|
The feasability will be assed by considering the number of participants reaching and using each method, and by recording the number of support intervention required for the use of each method.
|
At the end of the experimentation of the two methods (end of week 3)
|
|
Effectiveness
Time Frame: Within one month after the experimentation of the two methods.
|
After the adaptation of the two recommendations using the two methods, twenty experts, blind to the method used to formulate the recommendations, will rate each recommendation for its clarity, accuracy, appropriateness and usefulness of the recommendations using 10 points likert scales.
An electronic questionnaire will be send to the experts and they will have one week to rate the recommendations.
|
Within one month after the experimentation of the two methods.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2014
Primary Completion (Anticipated)
March 1, 2014
Study Completion (Anticipated)
March 1, 2014
Study Registration Dates
First Submitted
December 17, 2013
First Submitted That Met QC Criteria
December 23, 2013
First Posted (Estimate)
December 30, 2013
Study Record Updates
Last Update Posted (Estimate)
December 30, 2013
Last Update Submitted That Met QC Criteria
December 23, 2013
Last Verified
December 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KT Canada 87776
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Brain Injury
-
Brent MaselThe Moody FoundationCompletedChronic Traumatic Brain InjuryUnited States
-
University of TurkuTurku University Hospital; The Finnish Funding Agency for Technology and Innovation... and other collaboratorsCompletedBrain Injuries | TBI (Traumatic Brain Injury) | Brain Injuries, Traumatic | Traumatic Brain Injury | Injury, Brain, TraumaticFinland
-
University of Sao Paulo General HospitalUnknownTraumatic Brain Injury | Severe Brain Injury | Closed Traumatic Brain InjuryBrazil
-
BrainScope Company, Inc.Active, not recruitingTBI (Traumatic Brain Injury) | Concussion, Brain | MTBI - Mild Traumatic Brain Injury | Closed Head InjuryUnited States
-
Queen Mary University of LondonCompleted
-
Institut National de la Santé Et de la Recherche...Institut National de Recherche en Informatique et en AutomatiqueRecruitingTBI (Traumatic Brain Injury)France
-
Fondazione per la Ricerca Ospedale MaggioreCompletedBrain Injuries, Traumatic | Brain Injury Traumatic Severe | Brain Injury Traumatic ModerateItaly
-
Center for Vision Development, New Market, MarylandUnknownBrain Injuries | Brain Injuries, Traumatic | Traumatic Brain Injury | Brain Injury, Chronic | Injury, Brain, TraumaticUnited States
-
Assiut UniversityUnknown
-
Peking Union Medical College HospitalCompletedBrain-injury | Intracranial; Blood Vessel, InjuryChina
Clinical Trials on Focus group
-
Queen's University, BelfastCompletedAge Related Macular DegenerationUnited Kingdom
-
Istituto Scientifico Italiano Colonna VertebraleActive, not recruitingAdolescent Idiopathic Scoliosis (AIS)Italy
-
M.D. Anderson Cancer CenterCompletedPediatric CancersUnited States
-
Istanbul University - CerrahpasaRecruitingPatellofemoral Pain, PFPTurkey (Türkiye)
-
Universitair Ziekenhuis BrusselBrusselse Huisartsenkring (BHAK); Vlaamse Gemeenschapscommissie (VGC)RecruitingPrimary Health Care | Health Services Accessibility | Language | After-hours Care | Communication BarriersBelgium
-
Teesside UniversitySouth Tees Hospitals NHS Foundation TrustNot yet recruitingOveractive Bladder | Urinary Incontinence | Benign Prostatic Hyperplasia | Urinary Tract Infections | Urinary Retention | Underactive Bladder
-
University of Kansas Medical CenterEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedPregnancy RelatedUnited States
-
Beth FosterThe Hospital for Sick Children; University of Pittsburgh; Seattle Children's... and other collaboratorsCompletedTeen Adherence in KidnEy Transplant, Improving Tracking To Optimize Outcomes (Stage 1) (TAKE-IT TOO)Medication AdherenceCanada, United States
-
University of North Carolina, Chapel HillCompletedAcquired Immunodeficiency Syndrome
-
Sunnybrook Health Sciences CentreWithdrawnFocus of Study is on Dentist's Attitudes Toward BP MeasuresCanada